You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) MENTHOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing MENTHOL excipient, and estimated key patent expiration / generic entry dates

Market Dynamics and Financial Trajectory for Menthol in Pharmaceutical Excipients

Last updated: February 23, 2026

Menthol remains a high-demand pharmaceutical excipient primarily used for its cooling, anesthetic, and flavoring properties. The global market for menthol is driven by increasing demand in the pharmaceutical, food, and personal care sectors. Market growth expects a compound annual growth rate (CAGR) of approximately 4.2% from 2023 to 2028, reaching an estimated valuation of $600 million by 2028.

Market Overview

Market Size and Historical Growth

  • 2022 valuation: ~$420 million
  • Projected 2028 valuation: ~$600 million
  • CAGR (2023-2028): 4.2%

Key Applications

  • Pharmaceuticals: Used as an excipient, flavoring agent, and topical anesthetic in cold relief products, inhalers, and ointments.
  • Food Industry: Flavor additive in chewing gums, candies, and beverages.
  • Personal Care: Incorporated into cosmetics, mouthwashes, and skincare products.

Regional Market Breakdown

Region Share (2022) Growth Rate (2023-2028) Key Markets
Asia-Pacific 50% 4.5% China, India, Japan
North America 25% 3.8% US, Canada
Europe 15% 3.5% Germany, UK
Rest of World 10% 4.0% Brazil, South Africa

Production & Supply

Menthol is primarily derived from natural sources such as mint oils and green tea leaves, with synthetic menthol accounting for forward integration and cost reduction strategies. The two major suppliers globally are India and China, collectively supplying over 70% of the product volume.

Market Drivers

  • Growth of Cold and Cough Products: Increased demand for OTC cold remedies enhances menthol's use as an active ingredient.
  • Rising Demand for Natural Products: Consumer preference for natural menthol from mint oils influences production.
  • Pharmaceutical R&D: New formulations in nasal sprays, inhalers, and topical analgesics favor menthol inclusion.
  • Expanding Personal Care Market: Menthol's cooling effect boosts its application in skin care and cosmetic products.

Market Restraints

  • Regulatory Challenges: Variations in permissible concentrations in pharmaceutical and food products can impede market expansion.
  • Synthetic Menthol Competition: Cost advantages of synthetic menthol may affect natural menthol growth.
  • Environmental Concerns: Production processes involving solvent extraction and chemical synthesis face scrutiny over sustainability.

Financial Trajectory & Investment Outlook

Revenue Trends

Menthol sales in the pharmaceutical sector increased at an average annual rate of 4.5% from 2018-2022. The pandemic accelerated demand for menthol-based cold remedies, with sales growth topping 6% in 2020.

Key Companies & Market Share

Company Market Share Notable Operations
Wintus Limited (India) 25% Global supplier of natural and synthetic menthol
Symrise AG (Germany) 12% Produces menthol for flavoring and fragrance applications
Capot Chemical (China) 10% Major synthetic menthol producer
Other players 53% Includes regional suppliers

R&D and Patent Filings

Patent filings for menthol synthesis methods focus on bio-based production and environmentally friendly catalysts. As of 2022, over 30 patents related to natural extraction processes and synthetic pathways have been filed globally.

Future Investment Opportunities

  • Natural Extraction Enhancements: Investment in sustainable mint cultivation and extraction techniques.
  • Synthetic Process Innovation: Development of greener, cost-efficient synthesis methods.
  • Product Diversification: Formulation of menthol derivatives for specialized pharmaceutical and cosmetic uses.

Regulatory and Policy Landscape

  • FDA (United States): Menthol used as an excipient is Generally Recognized As Safe (GRAS). Maximum permissible concentrations in OTC cold products are specified.
  • EMA (European Union): Sets limits on natural menthol concentrations for medicinal products and foodstuffs.
  • Cosmetic Regulations: Menthol's inclusion in cosmetic formulations regulated under EU Cosmetics Regulation (EC) No 1223/2009.

Key Risks and Opportunities

Risks Opportunities
Regulatory variability across regions Expansion in emerging markets
Price volatility of natural mint oils Innovation in synthetic, eco-friendly menthol production
Environmental sustainability concerns Growth in natural and organic product segments

Key Takeaways

  • The global menthol market is expanding at a CAGR of 4.2%, driven by pharmaceutical, food, and personal care demand.
  • Natural menthol extraction from mint oils dominates supply, but synthetic menthol holds cost advantages.
  • Major suppliers are India and China, accounting for significant share.
  • Regulatory frameworks influence market growth, with increasing emphasis on sustainability.
  • Investment focuses on process innovation, sustainable cultivation, and diversification into specialty derivatives.

FAQs

Q1: What are the primary uses of menthol in pharmaceuticals?
Menthol is used as an excipient for flavoring, a topical analgesic, and as an inhalational agent in cold relief products.

Q2: Which regions dominate the menthol market?
Asia-Pacific leads with 50% of the market share, followed by North America and Europe.

Q3: How does natural menthol production compare to synthetic?
Natural menthol is extracted from mint oils and is preferred for natural product formulations but involves higher costs. Synthetic menthol is cheaper and accounts for over 50% of production.

Q4: What are the growth drivers for the menthol market?
Growth drivers include increased demand for cold remedies, natural product trends, and innovation in pharmaceutical formulations.

Q5: What is the outlook for investment in menthol technology?
Investments focus on eco-friendly synthesis, sustainable cultivation, and expanding applications in emerging markets and new product segments.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.